Researchers at Oregon Health & Science University have developed a new molecule that may open the door to treating difficult cases of triple-negative breast cancer, a particularly aggressive form of the disease that currently has few effective…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply